Device-detected A Fib: NOAH-AFNET 6 & ARTESIA - Prof. Jeff Healey, Prof. Paulus Kirchhof

Device-detected A Fib: NOAH-AFNET 6 & ARTESIA - Prof. Jeff Healey, Prof. Paulus Kirchhof

Share:

Similar Tracks

Emory Cardiology Friday Fellows Conference Journal Club 10-20-2023 Emory Cardiology

Bass Pro Shops CHEAP vs EXPENSIVE Budget Fishing Challenge! KickinTheirBASSTV

Aspirin for 1° and 2° Prevention of ASCVD – Prof. Mora (Boston, MA), Prof. Cleland (Glasgow, UK) MARKUS at HOMe

Obinutuzumab in Lupus Nephritis - REGENCY - Prof. Dr. Brad Rovin, Prof. Dr. Ana Malvar MARKUS at HOMe

Heart Rhythm TV Update: The ARTESIA Trial Heart Rhythm TV

Remnant Cholesterol - Focus CKD - Prof. Dr. Borge Nordestgaard (Copenhagen, Denmark) MARKUS at HOMe

Obama's 2004 DNC keynote speech CNN

The rise of Xi Jinping, explained Vox

Hot Topics of AF Screening and Subclinical AF - Grand Rounds with Jeff Healey, MD University of Ottawa Heart Institute

Think Faster, Talk Smarter with Matt Abrahams Stanford Alumni

Subclinical Atrial Fibrillation: Connecting Evidence to Practice Anticoagulation Forum

Tirzepatide for HFPEF and Obesity - SUMMIT - Prof. Dr. Barry A Borlaug (Rochester, MN, USA) MARKUS at HOMe

Nephroprotection 2025: "4 Pillars" & EASi-KIDNEY - Dr. Doreen Zhu & Dr. Parminder Judge (Oxford, UK) MARKUS at HOMe

ATTICUS trial of apixaban vs aspirin for secondary prevention after ESUS: findings & implications VJNeurology

The CETP-Inhibitor Obicetrapib in FH: BROOKLYN - Prof. Dr. Stephen Nicholls (Melbourne, Australia) MARKUS at HOMe

Think Fast, Talk Smart: Communication Techniques Stanford Graduate School of Business

Cardiac Arrest - ACLS Review ICU Advantage

Immune Checkpoint-Inhibitor-Associated AKI - Prof. Dr. Sandra Herrmann (Rochester, MN, USA) MARKUS at HOMe